Xenios AG
Develops medical devices for lung and heart treatments.
Launch date
Employees
Company register number HRB 743620 (Stuttgart)
Heilbronn Baden-Württemberg (HQ)
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenues | 1.9m | - | - | - | - | - | - |
| EBITDA | (1.7m) | (13.0m) | (3.7m) | (8.4m) | (36.3m) | (23.4m) | (22.7m) |
| % EBITDA margin | (89 %) | - | - | - | - | - | - |
| Profit | (2.4m) | (14.9m) | (4.7m) | (11.5m) | (39.9m) | (2.5m) | (7.3m) |
| % profit margin | (125 %) | - | - | - | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Seed | ||
N/A | Acquisition | ||
| Total Funding | - | ||
Recent News about Xenios AG
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Xenios AG
Edit
ACQUISITION by Xenios AG Jun 2013
